Aethlon Medical Inc

NASDAQ:AEMD  
5.20
-0.16 (-2.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)61.44M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.36 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$5.12
50-Day MA$2.58
200-Day MA$2.10
See more pivots

Aethlon Medical Inc Stock, NASDAQ:AEMD

9635 Granite Ridge Drive, Suite 100, San Diego, California 92123
United States of America
Phone: +1.858.459.7800
Number of Employees: 8

Description

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.